Updated on 15 August 2012
Further, Cipla's introduction of the Duovir-E Kit (Ziodovudine + Lamivudine + Efavirenz) in 2004 and the Odivir Kit (Didanosine + Lamivudine + Efavirenz) in 2003 were significant contributions towards managing and living with HIV/AIDS.
According to reports, the number of HIV infected people continues to grow. At the end of 2010, about 34 million people were living with HIV and there were 2.7 million new infections in that year. HIV patients have to take multiple medicines lifelong. Every year about five-to-10 percent of patients fail their first line treatment due to various reasons such as missing doses and the virus developing resistance.